Institutional Fund
Johnson & Johnson
New Brunswick, NJCIK 2004067 filings on record
Portfolio Value
$652.36M
Q1 2026
Holdings
16
Reported positions
New Buys
1
Opened this quarter
QoQ Change
+17.5%
from $555.05M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Protagonist Therapeutics Inc39.6%
- Nanobiotix26.6%
- Meiragtx Hldgs PLC8.8%
- Rapport Therapeutics Inc8.6%
- Cvrx Inc5.8%
- Contineum Therapeutics Inc4.0%
- Other6.6%
Portfolio Holdings
16 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc | 2.45M | $258.14M | 39.6% | 0 | Held |
| 2 | Nanobiotix | 5.62M | $173.61M | 26.6% | 0 | Held |
| 3 | Meiragtx Hldgs PLC | 6.64M | $57.51M | 8.8% | 0 | Held |
| 4 | Rapport Therapeutics Inc | 1.78M | $55.84M | 8.6% | 0 | Held |
| 5 | Cvrx Inc | 4.02M | $38.08M | 5.8% | 0 | Held |
| 6 | Contineum Therapeutics Inc | 1.98M | $25.85M | 4.0% | 0 | Held |
| 7 | Legend Biotech Corp | 814.6K | $14.74M | 2.3% | 0 | Held |
| 8 | Xencor Inc | 748.1K | $9.02M | 1.4% | 0 | Held |
| 9 | Procept Biorobotics Corp | 357.9K | $8.95M | 1.4% | 0 | Held |
| 10 | Fate Therapeutics Inc | 3.38M | $4.05M | 0.6% | 0 | Held |
6 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio